Edition:
United States

Sustainable Business

Breakingviews

Breakingviews - Takeda feeling uncomfortable Shire side effects

Takeda Pharmaceutical is showing signs of recovery after a mega-merger, but shareholders keep feeling the pain. Some 18 months after completing a $62 billion takeover of Irish rival Shire, the Japanese drugmaker may sell another business to further pare debt. Promised cost savings are also materialising. A weak stock performance, however, suggests Chief Executive Christophe Weber overpaid.

Video

Featured Topics

More Sustainability Coverage

UK regulator proposes network overhaul for green energy drive

British energy regulator Ofgem said energy network operators should invest 25 billion pounds ($32 billion) from 2021 to 2026 to deliver emissions-free energy and proposed cutting returns these companies can make in order to reduce household bills.

2019 Thomson Reuters Sustainability Report

The Pathway to Leadership for Carbon Intensive Businesses

Download now »

Interactive

Reuters Sustainability: Autos

Business model transformation and decarbonization within the autos sector

Executive Perspectives

This section combines expertise from Thomson Reuters and valued external Partners